Adjuvant vs neoadjuvant chemotherapy in resectable NSCLC: is that the real question?
Strauss
Gary M
GM
Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015201:Meta-Analysis as Topic; D020360:Neoadjuvant Therapy; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents